Long-term persistence of HIV with drug resistance after CD4 cell count-guided structured treatment interruption

被引：3

作者：

Halfon, P

Pénaranda, G

Khiri, H

Xerridat, B

机构：

[1] Hop Ambroise Pare, F-13006 Marseille, France

[2] Hop Prive Clairval, F-13009 Marseille, France

来源：

AIDS | 2005年 / 19卷 / 15期

关键词：

D O I：

10.1097/01.aids.0000184404.37282.8f

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1713 / 1714

页数：2

共 8 条

[1] A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection [J].

Cardiello, PG ;

Hassink, E ;

Ananworanich, J ;

Srasuebkul, P ;

Samor, T ;

Mahanontharit, A ;

Ruxrungtham, K ;

Hirschel, B ;

Lange, J ;

Phanuphak, P ;

Cooper, DA .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (04) :594-600

[2] Long-term clinical follow-up, without antiretroviral therapy, of patients with chronic HIV-1 infection with good virological response to structured treatment interruption [J].

Florence, E ;

García, F ;

Plana, M ;

Fumero, E ;

Castro, P ;

Lopez, A ;

Cruceta, A ;

Gil, C ;

Arnedo, M ;

Miró, JM ;

Pumarola, T ;

Gallart, T ;

Gatell, JM .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) :569-574

[3] Kinetics of disappearance of resistance mutations and reappearance of wild-type during structured treatment interruptions [J].

Halfon, P ;

Durant, J ;

Clevenbergh, P ;

Carsenti, H ;

Celis, L ;

Khiri, H ;

De Smet, K ;

De Brauwer, A ;

Hulstaert, F ;

Dellamonica, P .

AIDS, 2003, 17 (09) :1351-1361

[4] Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial [J].

Maggiolo, F ;

Ripamonti, D ;

Gregis, G ;

Quinzan, G ;

Callegaro, A ;

Suter, F .

AIDS, 2004, 18 (03) :439-446

[5] Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment [J].

Nuesch, R ;

Ananworanich, J ;

Sirivichayakul, S ;

Ubolyam, S ;

Siangphoe, U ;

Hill, A ;

Cooper, D ;

Lange, J ;

Phanuphak, P ;

Ruxrungtham, K .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (05) :728-734

[6] Compartmentalization of drug resistance-associated mutations in a treatment-naive HIV-infected female [J].

Tirado, G ;

Jove, G ;

Kumar, R ;

Noel, RJ ;

Reyes, E ;

Sepulveda, G ;

Yamamura, Y ;

Kumar, A .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (06) :684-686

[7]

Torti Carlo, 2003, Med Sci Monit, V9, pCS16

[8] Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection [J].

Trkola, A ;

Kuster, H ;

Leemann, C ;

Ruprecht, C ;

Joos, B ;

Telenti, A ;

Hirschel, B ;

Weber, R ;

Bonhoeffer, S ;

Günthard, HF .

JOURNAL OF VIROLOGY, 2003, 77 (24) :13146-13155

← 1 →